SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-24-010987
Filing Date
2024-04-04
Accepted
2024-04-04 06:06:51
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A dmtp20240327_defa14a.htm DEFA14A 7523
2 pc01.jpg GRAPHIC 111552
3 pc02.jpg GRAPHIC 97021
4 pic1.jpg GRAPHIC 9640
  Complete submission text file 0001437749-24-010987.txt   309438
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36291 | Film No.: 24821549
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)